The sense of stopping migraine prophylaxis - The Journal of Headache and Pain

France Nouvelles Nouvelles

The sense of stopping migraine prophylaxis - The Journal of Headache and Pain
France Dernières Nouvelles,France Actualités
  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 71%

A Review published in the Journal of Headache and Pain explores both the biological and clinical rationale for stopping migraine prophylactic therapies.

There remains controversy over whether, in the case of adverse events, we stop a medication completely, or switch to another medication in the same class, i.e. CGRP targeted mAbs. Patients will additionally have differing levels of tolerability, with some people unwilling to remain on a medication with mild side effects, to others tolerating ‘worse’ side effects when weighed up against the severity of their migraines.

For onabotulinumtoxinA, in contrast, stopping rules are longer than those of oral preventive drugs. This is due to its intramuscular administration, which bypasses metabolization via the gastro-intestinal route and avoids interactions with e.g. cytochrome P450 enzymes, in contrast to oral preventives.

For our included studies, the duration is often six months to one year. This highlights the need for longer studies investigating long-term efficacy and long-term discontinuation effects. As gepants and CGRP targeted mAbs become more widely available to EM and CM patients, more robust clinical trials will need to be conducted – not only looking at efficacy, but also discontinuation effects.

]. Ultimately, the identification of objective biomarkers for disease improvement and prognostic features of treatment relapse would bring advantages in determining whether and which migraine patients would benefit from discontinuing migraine prophylaxis.Current guidelines advise clinicians to assess the success of CGRP targeted mAbs after three months and to continue when the treatment is successful.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

BioMedCentral /  🏆 22. in UK

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Hotmail's epic spam fail is the latest headache for MicrosoftHotmail's epic spam fail is the latest headache for MicrosoftGetting loads of spam? Don't worry - it's not just you.
Lire la suite »

Wild Hearts devs fix the hellish RX 7900 XTX 'disco lights' headacheWild Hearts devs fix the hellish RX 7900 XTX 'disco lights' headacheThe new patch also undoes the 'unintentional' high-end CPU frame caps, along with fixes for a bunch of other issues.
Lire la suite »

Multimorbidity in patients with low back pain in Danish chiropractic practice: a cohort study - Chiropractic & Manual TherapiesMultimorbidity in patients with low back pain in Danish chiropractic practice: a cohort study - Chiropractic & Manual TherapiesBackground People with multimorbidity, defined as the co-existence of two or more chronic conditions in an individual, often suffer from pain and functional limitations caused by musculoskeletal disorders and the chronic conditions. In chiropractic practice, two thirds of patients are treated for low back pain (LBP). It is unknown to what extent LBP is accompanied with chronic conditions in chiropractic practice. The objective was to determine the prevalence of multimorbidity among patients with LBP in chiropractric practice and to investigate if multimorbidity affects pain intensity, self-rated health, physical and mental health. Finally, to explore if individuals with multimorbidity have a different recovery for the LBP. Methods Patients presenting with a new episode of LBP were recruited from 10 chiropractic clinics in 2016–2018. Patient-reported data concerning socio-demographics, self-rated health, pain intensity, history of LBP, mental health and chronic conditions were collected at baseline. The prevalence of multimorbidity was determined. To evaluate differences in recovery from the LBP, we estimated changes in the Roland Morris Disability Questionnaire (RMDQ) score and use of pain medication at baseline, 2 weeks, 3 months and 12 months. The analyses were adjusted using regression models. Results 2083 patients were included at baseline and 71%, 68% and 64% responded to follow-up questionnaires at 2 weeks, 3 and 12 months. 1024 (49%) participants reported to have at least one chronic condition and 421 (20%) had multimorbidity (≥ 2 chronic conditions). The presence of multimorbidity was associated with increased odds of poor self-rated health (OR 2.13), physical fitness (OR 1.79), poor muscular strength (OR 1.52), poor endurance (OR 1.51), and poor balance (OR 1.33). Patients with high LBP intensity combined with multimorbidity showed a poorer recovery than patients without chronic diseases (mean difference in RMDQ score 3.53 at 12 months follow-up). More pati
Lire la suite »

Klopp reveals pain of rewatching Champions League final as Real Madrid reunion loomsKlopp reveals pain of rewatching Champions League final as Real Madrid reunion loomsJurgen Klopp has revealed he’s been avoiding rewatching last season’s Champions League final. But with Liverpool facing the side that defeated them last May on Tuesday, the Reds boss ad…
Lire la suite »

Florence Pugh struggling with 2-day hangover after partying after BaftasFlorence Pugh struggling with 2-day hangover after partying after BaftasFlorence Pugh admitted she was still nursing a hangover two days on from partying after the Baftas...we've all been there, don't worry 🤒
Lire la suite »

Yes, you can make air fryer pancakes, but you could also ruin Pancake DayYes, you can make air fryer pancakes, but you could also ruin Pancake DayMaking was a pain, but the results were delicious
Lire la suite »



Render Time: 2025-02-27 18:23:27